Table: Cosmos Pharmaceutical - 6-MTH group results
Jan 11 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2021 Nov 30, 2020 May 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 371.14 364.18 750.00
(+12.0 pct)
Operating 14.98 18.29 33.20
(+52.9 pct)
Recurring 16.49 19.55 35.90
(+49.1 pct)
Net 11.25 13.07 25.00
(+49.0 pct)
EPS 283.99 yen 330.12 yen 631.33 yen
Ann Div 70.00 yen 80.00 yen
-Q2 div 40.00 yen 27.50 yen
-Q4 div 42.50 yen 40.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T